AioCare news

The role of spirometry in diagnosing and monitoring chronic obstructive airway diseases is crucial. According to WHO, the demonstration of irreversible airway obstruction is essential for diagnosing chronic obstructive pulmonary disease (COPD), which is the third leading cause of death worldwide.
It is estimated that up to 67–81% of patients with COPD remain undiagnosed.
Mobile phone-linked spirometers can be used almost anywhere – at smal

Ambient air pollution has many detrimental health effects, causing about seven million premature deaths annually worldwide. Children are particularly susceptible to the effects of ambient air pollution because their respiratory systems are immature.
The air quality in Zabrze, a city located in the Upper Silesian Industrial Region of Poland, is among the worst in Europe. In cooperation with Polish scientists and pollution res

The Journal of Asthma published the results of a study that assessed asthma patients and their ability to perform high-quality daily spirometry with the AioCare system. The study has shown that home spirometry is safe without supervision and feasible for asthma patients. 

Abstract:
Background: Self-management is an appealing strategy for the prevention of asthma exacerbations. This study aimed to evaluate the feasibility and safety of a portable spirometer

AioCare’s R&D team has created an AI algorithm for automatic detection of cough during spirometry testing. It was possible thanks to using neural networks and machine learning technology. The article has been published in the Informatics in Medicine Unlocked. To build the algorithm a considerable data set (about 20,000 spirometry records) was used, obtaining 93% detection accuracy. It is the first open-source article on how to detect coughing from an

The AioCare system is used as a home self-monitoring tool in a prospective, observational cohort study of a drug for severe eosinophilic asthma, produced by one of the world’s pharmaceutical concerns. Fifty adult patients diagnosed with severe eosinophilic asthma (defined by blood eosinophilia ≥300 cells / μl and at least three asthma exacerbations in the previous year) will be recruited for the study. To check patients’ condition, the University of Vienna Hospital together